TH64472A - Single dose vaccination containing Mycoplasma Hyopneumoniae. - Google Patents
Single dose vaccination containing Mycoplasma Hyopneumoniae.Info
- Publication number
- TH64472A TH64472A TH201002433A TH0201002433A TH64472A TH 64472 A TH64472 A TH 64472A TH 201002433 A TH201002433 A TH 201002433A TH 0201002433 A TH0201002433 A TH 0201002433A TH 64472 A TH64472 A TH 64472A
- Authority
- TH
- Thailand
- Prior art keywords
- vaccine
- hyo
- single dose
- mycoplasma hyopneumoniae
- prepare
- Prior art date
Links
- 241000204045 Mycoplasma hyopneumoniae Species 0.000 title claims abstract 3
- 238000002255 vaccination Methods 0.000 title 1
- 229960005486 vaccine Drugs 0.000 claims abstract 6
- 241001465754 Metazoa Species 0.000 claims abstract 4
- 229940079593 drug Drugs 0.000 claims abstract 3
- 239000003814 drug Substances 0.000 claims abstract 3
- 108700001237 Nucleic Acid-Based Vaccines Proteins 0.000 claims abstract 2
- 230000005856 abnormality Effects 0.000 claims abstract 2
- 230000015572 biosynthetic process Effects 0.000 claims abstract 2
- 201000010099 disease Diseases 0.000 claims abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract 2
- 208000015181 infectious disease Diseases 0.000 claims abstract 2
- 229940023146 nucleic acid vaccine Drugs 0.000 claims abstract 2
- 229940031626 subunit vaccine Drugs 0.000 claims abstract 2
- 238000003786 synthesis reaction Methods 0.000 claims abstract 2
- 101800004538 Bradykinin Proteins 0.000 claims 2
- QXZGBUJJYSLZLT-UHFFFAOYSA-N H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH Natural products NC(N)=NCCCC(N)C(=O)N1CCCC1C(=O)N1C(C(=O)NCC(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CO)C(=O)N2C(CCC2)C(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CCCN=C(N)N)C(O)=O)CCC1 QXZGBUJJYSLZLT-UHFFFAOYSA-N 0.000 claims 2
- 102100035792 Kininogen-1 Human genes 0.000 claims 2
- QXZGBUJJYSLZLT-FDISYFBBSA-N bradykinin Chemical compound NC(=N)NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(=O)NCC(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CO)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)CCC1 QXZGBUJJYSLZLT-FDISYFBBSA-N 0.000 claims 2
- 239000004480 active ingredient Substances 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 241001529453 unidentified herpesvirus Species 0.000 claims 1
- 238000000034 method Methods 0.000 abstract 1
Abstract
DC60 (30/07/52) การประดิษฐ์นี้เกี่ยวข้องกับวิธีสำหรับรักษา หรือป้องกันโรค หรือความผิดปกติในสัตว์ ซึ่งมี สาเหตุมาจากการติดเชื้อ ด้วย Mycoplasma hyopneumoniae (M.hyo) โดยการให้วัคซีน M.hyo ขนาดยาเดียวในปริมาณที่ให้ผลแก่สัตว์ที่อายุประมาณสาม (3) ถึงสิบ (10) วัน วัคซีน M.hyo นี้ สามารถเป็นเซลล์ทั้ง หมด หรือเซลล์บางส่วนที่ถูกทำให้เสื่อมฤทธิ์ หรือเตรียมแบบ มีชีวิตโดยได้รับ การปรับปรุง, วัคซีนชนิดซับยูนิต หรือ วัคซีนชนิดกรดนิวคลีอิก หรือ DNA วัคซีน M.hyo ที่ทำการให้ ตามการประดิษฐ์นี้สามารถผลิตได้โดยการสังเคราะห์ หรือแบบรี คอมไบแนนท์ สิทธิบัตรยา DC60 (30/07/52) This invention relates to a method for treating Or prevent disease Or animal abnormalities caused by infection with Mycoplasma hyopneumoniae (M.hyo) by administering a single dose of the M.hyo vaccine in doses administered to animals approximately three (3) to ten (10). This M.hyo vaccine can be whole or partial cells that have been degraded. Or prepare designs Live modified, subunit vaccine, or nucleic acid vaccine or DNA M.hyo vaccine following invention can be produced by synthesis or recombinant drug patent.
Claims (1)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TH64472A true TH64472A (en) | 2004-10-05 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2003003941A3 (en) | One dose vaccination with mycoplasma hyopneumoniae | |
| Roberts | Onychomycosis: current treatment and future challenges | |
| BR0211049A (en) | Method of treatment or prevention of disease or dysfunction and use of mycoplasma hyopneumoniae | |
| JP2002522485A5 (en) | ||
| WO2007122619A3 (en) | Tto-based wide spectrum therapeutics, disinfectants & anesthetics for use in aquaculture | |
| ATE373679T1 (en) | ANTIMICROBIAL OR ENDOTOXIN NEUTRALIZING POLYPEPTIDE | |
| AR039164A1 (en) | VENLAFAXINE SALTS OF LOW WATER SOLUBILITY | |
| UY27365A1 (en) | MYCOPLASMA BOVIS VACCINE AND METHODS TO REDUCE PNEUMONIA IN ANIMALS | |
| RU2008105348A (en) | LAWSONIA VACCINE AND ITS APPLICATIONS | |
| JP2004002429A5 (en) | ||
| AR039895A1 (en) | COMPOSITION THAT INCLUDES A VITAMIN, A METAL SALT AND AN INSULIN OR A HORMONE OF THE GROWTH AND USE OF SUCH COMPONENTS TO PREPARE IT | |
| TH64472A (en) | Single dose vaccination containing Mycoplasma Hyopneumoniae. | |
| EA200700176A1 (en) | PEPTIDE, NORMALIZING METABOLISM IN BONE AND NURSING TISSUES, PHARMACEUTICAL COMPOSITION ON ITS BASIS AND METHOD OF ITS APPLICATION | |
| Giammona et al. | 5PSQ-096 Hazard vulnerability analysis to evaluate the risk of drug shortages according to therapeutic class | |
| Gupta et al. | Itraconazole pulse therapy is effective in dermatophyte onychomycosis of the toenail: a double-blind placebo-controlled study | |
| RU2232501C2 (en) | Method for increasing natural resistance in animals | |
| JPH06340549A (en) | Therapeutic agent for feline respiratory organ disease and therapeutic method using the therapeutic agent | |
| RU2825226C1 (en) | Method for increasing immunogenicity of bacterial vaccine in calves | |
| RU2188001C2 (en) | Method for treating myxomatosis and viral hemorrhagic diseases in rabbits | |
| RU95107140A (en) | Method of treatment of generalized demodecosis form in dogs complicated with staphylococcus and fungal infection | |
| RU2258501C2 (en) | Method for applying ethidium bromide for treatment of horses with pyroplasmosis | |
| RU2184539C2 (en) | Method for prolonged chemoprophylaxis and treatment of anaplasmosis in sheep and goats | |
| RU2535007C1 (en) | Method of farm recovery from bovine necrobacteriosis | |
| RU2274452C1 (en) | Method for treating the cases of demodecosis aggravated by staphylococcus infection in animals | |
| RU2238759C2 (en) | Method for preventing brucellosis |